Intuitive Surgical (NASDAQ:ISRG) SVP Sells $2,463,120.00 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius sold 4,500 shares of the business’s stock in a transaction dated Friday, December 12th. The stock was sold at an average price of $547.36, for a total value of $2,463,120.00. Following the transaction, the senior vice president directly owned 907 shares of the company’s stock, valued at approximately $496,455.52. This represents a 83.23% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Mark Brosius also recently made the following trade(s):

• On Monday, December 15th, Mark Brosius sold 464 shares of Intuitive Surgical stock. The shares were sold at an average price of $548.49, for a total transaction of $254,499.36.

Intuitive Surgical Stock Up 0.4%

NASDAQ ISRG opened at $556.86 on Thursday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The firm has a 50 day moving average of $536.26 and a two-hundred day moving average of $505.77. The stock has a market capitalization of $199.62 billion, a PE ratio of 73.66, a price-to-earnings-growth ratio of 5.10 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The business had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company’s revenue was up 22.9% on a year-over-year basis. During the same period last year, the business earned $1.84 EPS. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the company. Brighton Jones LLC raised its position in Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares during the last quarter. Kovitz Investment Group Partners LLC increased its stake in Intuitive Surgical by 0.9% in the first quarter. Kovitz Investment Group Partners LLC now owns 7,847 shares of the medical equipment provider’s stock valued at $3,887,000 after purchasing an additional 72 shares during the period. Dimensional Fund Advisors LP raised its holdings in shares of Intuitive Surgical by 1.5% in the first quarter. Dimensional Fund Advisors LP now owns 574,954 shares of the medical equipment provider’s stock valued at $284,746,000 after buying an additional 8,521 shares during the last quarter. EverSource Wealth Advisors LLC boosted its stake in shares of Intuitive Surgical by 11.1% during the first quarter. EverSource Wealth Advisors LLC now owns 1,344 shares of the medical equipment provider’s stock worth $666,000 after buying an additional 134 shares during the period. Finally, Nations Financial Group Inc. IA ADV grew its holdings in shares of Intuitive Surgical by 7.1% during the first quarter. Nations Financial Group Inc. IA ADV now owns 888 shares of the medical equipment provider’s stock worth $440,000 after buying an additional 59 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

ISRG has been the topic of a number of recent analyst reports. Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a report on Monday. Mizuho set a $575.00 target price on Intuitive Surgical in a research note on Wednesday, October 22nd. UBS Group set a $600.00 price target on shares of Intuitive Surgical and gave the company a “neutral” rating in a research note on Thursday, October 23rd. Citigroup cut shares of Intuitive Surgical from a “buy” rating to a “neutral” rating and cut their price objective for the stock from $650.00 to $635.00 in a report on Thursday, December 11th. Finally, Sanford C. Bernstein restated an “outperform” rating and set a $685.00 price objective on shares of Intuitive Surgical in a research report on Tuesday, October 21st. Two research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $609.83.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.